17th Oct 2024
Solvotrin Announces Long-Term Licensing Agreement with NorwellTM Consumer Healthcare
October 17th, 2024 – Solvotrin Therapeutics, a leading Irish healthcare development company, is delighted to announce the signing of a long-term licensing agreement with NorwellTM Consumer Healthcare for the Active Iron brand in Canada*. NorwellTM Consumer Healthcare, an affiliate of Pharmascience, one of Canada's largest pharmaceutical manufacturers, is known for providing trusted over-the-counter (OTC) products to help meet the health and wellness needs of Canadians.
The partnership marks an exciting expansion opportunity for the clinically proven iron supplement which will be integrated into Norwell’s Women’s Health portfolio under WelivaTM.
"We're incredibly excited to launch in Canada," said Ronan McClafferty, Chief Operating Officer at Solvotrin. "This partnership is built on a shared vision of improving health outcomes, and we are confident that Norwell’s strong presence and expertise in Canada will help us make a meaningful impact on women's health."
David Bloom, General Manager of NorwellTM Consumer Healthcare, expressed his enthusiasm for the collaboration: "We are thrilled to partner with Solvotrin Therapeutics. At NorwellTM, we are always looking for clinically proven, innovative products that align with our mission of helping Canadians address their health and wellness needs. We believe Active Iron will be a unique product for women seeking a distinct iron supplement and an ideal fit for the brand.” Since its inception, NorwellTM Consumer Healthcare has established a strong reputation as a trusted partner in Canada, with a focus on providing over-the-counter products backed by scientific evidence. This new collaboration with Solvotrin further strengthens their portfolio and underscores their commitment to offering high-quality products that meet the evolving needs of Canadians.
About Solvotrin:
Solvotrin Therapeutics is an Irish healthcare development company focused on optimizing established therapies through innovation with patent protection. Solvotrin has developed and successfully commercialized the Active Iron platform technology, led by a range of advanced oral iron products branded as Active Iron, which is currently available in 15 markets worldwide.
About WelivaTM:
WelivaTM is a brand that supports women through various life stages by offering convenient products to help relieve symptoms related to hormonal changes and associated conditions.
About NorwellTM Consumer Healthcare:
NorwellTM Consumer Healthcare Inc. is a stand-alone consumer healthcare company that has the agility and flexibility to lead growth within the OTC category. NorwellTM Consumer Healthcare's vision is to help Canadians manage their health and wellbeing by offering trusted, clinically proven OTC products to meet their underserved health and wellness needs. Norwell's brand portfolio includes brands such as WelivaTM, Lax-A-Day®, Hemovel®, Cystoplus®, Helixia®, and Rhinaris®.
About Pharmascience:
Founded in 1983, Pharmascience Inc. is the largest Canadian-owned pharmaceutical company with 1,600 employees proudly headquartered in Montreal. Pharmascience Inc. is a full-service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 50 countries.
WelivaTM and its logo are trademarks owned by Norwell Consumer Healthcare Inc.
NORWELLTM is a trademark of Norwell Consumer Healthcare Inc.
« No reposting of this communication to any social media platform »
*Launch pending Health Canada submission and approval.